|
DE60131967D1
(de)
*
|
2001-08-13 |
2008-01-31 |
Phenex Pharmaceuticals Ag |
Nr1h4-kern-rezeptor-bindende verbindungen
|
|
US6953787B2
(en)
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
|
BR0311970A
(pt)
|
2002-06-19 |
2005-03-29 |
Biovitrum Ab |
Novos compostos, seu uso e preparação
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
US7132539B2
(en)
*
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
KR100547109B1
(ko)
*
|
2002-11-14 |
2006-01-26 |
삼성전자주식회사 |
자외선 흡수 치환기를 포함한 기능성 첨가제 및 이를포함하는잉크 조성물
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
CN1805938B
(zh)
|
2003-06-17 |
2010-06-16 |
艾尼纳制药公司 |
用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
|
|
US8367657B2
(en)
|
2003-06-17 |
2013-02-05 |
Arena Pharmaceuticals, Inc. |
Processes for preparing 3-benzazepines
|
|
MXPA05013365A
(es)
*
|
2003-06-20 |
2006-04-05 |
Arena Pharm Inc |
Derivados de n-fenil-piperazina y metodos para profilaxis o tratamiento de enfermedades asociadas con el receptor 5ht2c.
|
|
WO2005028438A1
(ja)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
新規ピペリジン誘導体
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
EP1586560A1
(en)
*
|
2004-04-13 |
2005-10-19 |
Cephalon, Inc. |
Thio-substituted arylmethanesulfinyl derivatives
|
|
US7297817B2
(en)
*
|
2004-04-13 |
2007-11-20 |
Cephalon France |
Thio-substituted arylmethanesulfinyl derivatives
|
|
JP5173190B2
(ja)
|
2004-08-25 |
2013-03-27 |
武田薬品工業株式会社 |
腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
|
|
DK1814590T4
(da)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals Llc |
Behandling af obesitet og beslægtede sygdomme.
|
|
GT200500317A
(es)
*
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
|
WO2006062110A1
(ja)
*
|
2004-12-06 |
2006-06-15 |
Banyu Pharmaceutical Co., Ltd. |
ピペラジン誘導体
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
EP2149562A1
(en)
|
2004-12-21 |
2010-02-03 |
Arena Pharmaceuticals, Inc. |
method of preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
EP1892241B1
(en)
|
2005-05-30 |
2016-03-30 |
Msd K.K. |
Novel piperidine derivative
|
|
AR054849A1
(es)
*
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
EP2330125A3
(en)
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
US7875633B2
(en)
|
2005-08-24 |
2011-01-25 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
RU2428423C2
(ru)
|
2005-11-10 |
2011-09-10 |
Баниу Фармасьютикал Ко., Лтд. |
Азазамещенные спиропроизводные
|
|
TW200734334A
(en)
*
|
2006-01-13 |
2007-09-16 |
Wyeth Corp |
Treatment of substance abuse
|
|
JP2009531435A
(ja)
*
|
2006-03-24 |
2009-09-03 |
ワイス |
うつ病の治療用の新規な治療組み合わせ
|
|
CA2646044A1
(en)
|
2006-04-03 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
|
|
JP5528699B2
(ja)
|
2006-05-16 |
2014-06-25 |
武田薬品工業株式会社 |
縮合複素環化合物およびその用途
|
|
AU2007300627B2
(en)
|
2006-09-22 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
EP2072519A4
(en)
|
2006-09-28 |
2009-10-21 |
Banyu Pharma Co Ltd |
DIARYLKETIMINDERIVAT
|
|
EP2099743B1
(en)
|
2006-12-05 |
2014-08-27 |
Arena Pharmaceuticals, Inc. |
Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
|
|
SG178716A1
(en)
|
2007-01-16 |
2012-03-29 |
Ipintl Llc |
Novel composition for treating metabolic syndrome
|
|
AU2008233662B2
(en)
|
2007-04-02 |
2012-08-23 |
Msd K.K. |
Indoledione derivative
|
|
CA2686926C
(en)
|
2007-05-14 |
2016-01-05 |
Sk Holdings Co., Ltd. |
Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
CL2008002777A1
(es)
*
|
2007-09-21 |
2010-01-22 |
Wyeth Corp |
Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario.
|
|
JP5520051B2
(ja)
|
2007-11-15 |
2014-06-11 |
武田薬品工業株式会社 |
縮合ピリジン誘導体およびその用途
|
|
US8093248B2
(en)
|
2007-12-05 |
2012-01-10 |
Astrazeneca Ab (Publ) |
Compounds useful for the treatment of conditions associated with weight gain
|
|
US8822727B2
(en)
|
2008-03-04 |
2014-09-02 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
|
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
|
CA2717384A1
(en)
|
2008-03-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
CA2666036C
(en)
|
2008-05-16 |
2017-09-12 |
Chien-Hung Chen |
Novel compositions and methods for treating hyperproliferative diseases
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
JP2011522006A
(ja)
*
|
2008-06-04 |
2011-07-28 |
アストラゼネカ アクチボラグ |
新規化合物ｖ
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
US20110124674A1
(en)
|
2008-07-30 |
2011-05-26 |
Hiroyuki Kishino |
5/5-or 5/6-membered condensed ring cycloalkylamine derivative
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
MX2011004551A
(es)
|
2008-10-30 |
2011-05-25 |
Merck Sharp & Dohme |
Antagonistas del receptor de orexina de isonicotinamida.
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
WO2010148207A2
(en)
|
2009-06-18 |
2010-12-23 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 5-ht2c receptor agonists
|
|
WO2011071136A1
(ja)
|
2009-12-11 |
2011-06-16 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
WO2011153206A1
(en)
|
2010-06-02 |
2011-12-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 5-ht2c receptor agonists
|
|
JP2013539470A
(ja)
|
2010-09-01 |
2013-10-24 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
ロルカセリンと光学活性な酸との塩
|
|
EA201390335A1
(ru)
|
2010-09-01 |
2013-09-30 |
Арена Фармасьютикалз, Инк. |
Введение лоркасерина индивидуумам с почечной недостаточностью
|
|
KR20180118801A
(ko)
|
2010-09-01 |
2018-10-31 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
|
|
KR20130101524A
(ko)
|
2010-09-01 |
2013-09-13 |
아레나 파마슈티칼스, 인크. |
5-ｈｔ2ｃ 아고니스트의 비-흡습성 염
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
ES2556460T3
(es)
*
|
2010-09-29 |
2016-01-18 |
Sk Biopharmaceuticals Co., Ltd. |
Derivados novedosos de metilciclohexano y usos de los mismos
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
MX357121B
(es)
|
2011-03-01 |
2018-06-27 |
Synergy Pharmaceuticals Inc Star |
Proceso de preparacion de agonistas c de guanilato ciclasa.
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2674670C1
(ru)
|
2012-10-09 |
2018-12-12 |
Арена Фармасьютикалз, Инк. |
Способ коррекции массы тела
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
CN103265498A
(zh)
*
|
2013-05-14 |
2013-08-28 |
广州科瑞生物技术有限公司 |
反式2,6-二甲基哌嗪的新工艺
|
|
PL3004138T3
(pl)
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
BR112017003745A2
(pt)
|
2014-08-29 |
2017-12-05 |
Tes Pharma S R L |
inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
WO2019131902A1
(ja)
|
2017-12-27 |
2019-07-04 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
|
EP3883930A1
(en)
|
2018-11-20 |
2021-09-29 |
Tes Pharma S.r.l. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
US11098029B2
(en)
|
2019-02-13 |
2021-08-24 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
|
WO2020167701A1
(en)
|
2019-02-13 |
2020-08-20 |
Merck Sharp & Dohme Corp. |
Pyrrolidine orexin receptor agonists
|
|
EP4010314B1
(en)
|
2019-08-08 |
2024-02-28 |
Merck Sharp & Dohme LLC |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
CN111646949B
(zh)
*
|
2020-06-12 |
2021-03-30 |
上海馨远医药科技有限公司 |
一种2,6-二甲基哌嗪二盐酸盐的制备方法
|
|
US20230365533A1
(en)
|
2020-08-18 |
2023-11-16 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|
|
CN116855568A
(zh)
*
|
2022-03-26 |
2023-10-10 |
重庆博腾制药科技股份有限公司 |
酶拆分法制备（s）-2-哌嗪乙腈及其盐酸盐
|